electroCore raises USD40m to fund commercialisation of gammaCore
electroCore, a company developing non-invasive Vagal Nerve Stimulation (nVNS) therapeutic devices to treat a range of medical conditions including primary headaches, has raised USD40m from Merck’s Global Healthcare Innovation Fund and private equity groups Easton Capital and Core Ventures. The capital will be used to finance commercialisation of the


